This agent has been evaluated in models of IR and cardiac arrest and shown to inhibit DRP1-mediated fission, diminish ROS generation and release of cytochrome c, attenuate indices of mitochondrial dysfunction and reduce myocardial infarct size [24,185]. Here, DNM1L is linked to myocardial infarction.